Primary record
1(2H)-PYRIMIDINEACETAMIDE, N-((1S,3S,4S)-4-((2-(2,6-DIMETHYLPHENOXY)ACETYL)AMINO)-3-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL)TETRAHYDRO-.ALPHA.-(1-METHYLETHYL)-2,4-DIOXO-, (.ALPHA.S)-
- 库存
- 6,458 克
- 纯度
- 98.5 %
- CAS
- 192725-39-6
化合物标识与属性
- CAS
- 192725-39-6
- PubChem CID
- 486506
- SMILES
- CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCC(=O)NC4=O)O
- Canonical SMILES
- Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCC(=O)NC1=O
名称与同义词
- Lopinavir Metabolite M-1
- 4-Oxolopinavir
- 4-Oxo-lopinavir
- Lopinavir (m1)
- Lopinavir Metabolite M1
- FA4KE7HY7K
- UNII-FA4KE7HY7K
- Lopinavir M1 metabolite
- AC1LAED8
- CHEMBL30185
- Lopinavir impurity E [WHO-IP]
- 192725-39-6
- orb1984684
- AIDS211894
- GLXC-15404
- BDBM50099842
- CID486506
- ZINC28766363
- AKOS040757133
- HY-136703
- CS-0133380
- (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-2-(2,4-dioxo-1,3-diazinan-1-yl)-3-methylbutanamide
- J1.169.279F
- DES(2-oxo-tetrahydropyrimidinyl)-2,4-dioxo-tetrahydropyrimidinyllopinavir
- 1(2H)-Pyrimidineacetamide, N-((1S,3S,4S)-4-((2-(2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2,4-dioxo-, (alphaS)-
- (|AS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-|A-(1-methylethyl)-2,4-dioxo-1(2H)-pyrimidineacetami-de
- (2S)-N-[(1S,3S,4S)-1-Benzyl-3-hydroxy-4-(2,6-dimethylphenoxyacetylamino)-5-phenylpentyl]-2-(2,4-dioxohexahydropyrimidine-1-yl)-3-methylbutanamide
- (2S)-N-[(1S,3S,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-pentyl]-2-(2,4-dioxohexahydropyrimidin-1-yl)-3-methyl-butanamide
- (2S)-N-[(2S,4S,5S)-5-[2-(2,6-DIMETHYLPHENOXY)ACETAMIDO]-4-HYDROXY-1,6-DIPHENYLHEXAN-2-YL]-2-(2,4-DIOXO-1,3-DIAZINAN-1-YL)-3-METHYLBUTANAMIDE
- (alphaS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2,4-dioxo-1(2H)-pyrimidineacetami- de
- (As)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)Acetyl]Amino]-3-Hydroxy-5-Phenyl-1-(Phenylmethyl)Pentyl]Tetrahydro-A-(1-methylethyl)-2,4-Dioxo-1(2H)-Pyrimidineacetamide
- (S)-N-[(S)-4-[2-(2,6-Dimethyl-phenoxy)-acetylamino]-3-(S)-hydroxy-5-phenyl-1-((S)-phenylmethyl)-pentyl]-2-(2,4-dioxo-tetrahydro-pyrimidin-1-yl)-3-methyl-butyramide
- (S)-N-{(1S,3S,4S)-1-Benzyl-4-[2-(2,6-dimethyl-phenoxy)-ethanoylamino]-3-hydroxy-5-phenyl-pentyl}-2-(2,4-dioxo-tetrahydro-pyrimidin-1-yl)-3-methyl-butyramide
- 1(2H)-PYRIMIDINEACETAMIDE, N-((1S,3S,4S)-4-((2-(2,6-DIMETHYLPHENOXY)ACETYL)AMINO)-3-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL)TETRAHYDRO-.ALPHA.-(1-METHYLETHYL)-2,4-DIOXO-, (.ALPHA.S)-
- M-1
- N-[(1S,2S,4S)-4-[[(S)-2-[Hexahydro-2,4-dioxopyrimidine-1-yl]-3-methylbutyryl]amino]-2-hydroxy-1,4-dibenzylbutyl]-2-(2,6-dimethylphenoxy)acetamide
- N-[(3S,5S)-4-[2-(2,6-Dimethyl-phenoxy)-acetylamino]-3-hydroxy-5-phenyl-1-((S)-phenylmethyl)-pentyl]-2-(2,4-dioxo-tetrahydro-pyrimidin-1-yl)-3-(S)-methyl-butyramide